Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-067072
Filing Date
2025-05-08
Accepted
2025-05-08 16:30:22
Documents
82
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q stro-20250331.htm   iXBRL 10-Q 2745499
2 EX-10.1 stro-ex10_1.htm EX-10.1 82444
3 EX-10.2 stro-ex10_2.htm EX-10.2 39381
4 EX-10.3 stro-ex10_3.htm EX-10.3 81680
5 EX-10.4 stro-ex10_4.htm EX-10.4 70752
6 EX-31.1 stro-ex31_1.htm EX-31.1 16572
7 EX-31.2 stro-ex31_2.htm EX-31.2 16722
8 EX-32.1 stro-ex32_1.htm EX-32.1 8438
9 EX-32.2 stro-ex32_2.htm EX-32.2 8489
  Complete submission text file 0000950170-25-067072.txt   11105741

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT stro-20250331.xsd EX-101.SCH 1433949
84 EXTRACTED XBRL INSTANCE DOCUMENT stro-20250331_htm.xml XML 2045745
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

EIN.: 452441988 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38662 | Film No.: 25926773
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)